LET'S UNPICK THE SEAMS OF PHARMA R&D


What trends are en vogue? How is the global pipeline shaping up? Is China shaping pharma's future? Find answers beyond question with our full catalog of insights.

Here's what we have in store:

  • R&D Infographic – available now
  • R&D Review white paper – available now
  • NAS Infographic – coming soon
  • NAS Supplement report – coming soon
  • Live webinar – April 15, 2025

Pharma R&D Infographic
Discover the biggest trends at a glance – like how 4.6% global pipeline growth compares to previous years and how pharma measures up in the $8 trillion global healthcare market.
''
Pharma R&D Annual Review 2025
Take a closer look at the global drug
development pipeline’s biggest trends
and success stories, so you can turn last
year’s learnings into your strategy for
2025 and beyond.
''
Pharma R&D Annual Review 2025
Take a closer look at the global drug
development pipeline’s biggest trends
and success stories, so you can turn last
year’s learnings into your strategy for
2025 and beyond.
''
Pharma R&D Infographic
Discover the biggest trends at a glance – like how 4.6% global pipeline growth compares to previous years and how pharma measures up in the $8 trillion global healthcare market.
''
''
White Paper
Clinical

Pharma R&D Annual Review 2025

Take a closer look at the global drug development pipeline’s biggest trends and success stories, so you can turn last year’s learnings into your strategy for 2025 and beyond.

''''
Infographic
Clinical

NAS Infographic

Take a closer look at New Active Substances. Find out which drugs made it to the high street.

''
Report
Clinical

NAS Supplement

Delve deeper into the data to uncover the insights from last year’s New Active Substances developments and successful launches.

View all

UNMISSABLE

Pharma R&D Live Webinar

April 15 | 10am NYC | 3pm LDN

Book your place at our live webinar where our expert panel will be discussing the latest global drug development trends, highlighting the companies making bold statements in R&D, and revealing which therapeutic categories are en vogue right now – plus so much more.

MEET THE SPEAKERS

Headshot of Ian Lloyd.

IAN LLOYD

Senior Director for Pharmaprojects

For 33 years, Ian has been the chief author of the annual Pharma R&D Review. His data-driven insights and unique perspective are a staple in the pharmaceutical calendar. Our webinar is your opportunity to put your questions directly to Ian, and uncover new insights that could unlock your future strategy.

Headshot of Alexandra Shimmings.

ALEXANDRA SHIMMINGS

Executive Editor, Citeline Commercial

As the head of our European editorial team, Alex has covered breathroughs in R&D across a range of therapeutic areas, including infectious diseases, cardiology and cancer. She frequently interviews key players in the industry, keeping her finger on the pulse of the global pharma R&D landscape.

PHARMAPROJECTS

The perfect fit for drug development

The Pharma R&D Review white papers and infographics are powered by data from Pharmaprojects, the industry’s leading platform for tracking and analyzing the global drug R&D landscape.

Book a free demo with one of our experts to discover the benefits of Pharmaprojects, including…

  • Track Global Drug Pipelines
  • Assess the Competitive Landscape
  • Identify R&D Opportunities
  • Monitor Key Market Trends
  • Access Expert Analyst Support